BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19438606)

  • 1. An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease.
    Lemmers A; Gustot T; Durnez A; Evrard S; Moreno C; Quertinmont E; Vercruysse V; Demetter P; Franchimont D; Le Moine O; Geerts A; Devière J
    Clin Exp Immunol; 2009 Jun; 156(3):518-27. PubMed ID: 19438606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy.
    Chen H; Zhang X; Liao N; Wen F
    Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
    Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
    Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
    J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
    Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Hum Immunol; 2006; 67(1-2):27-32. PubMed ID: 16698422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble glycoprotein 130 is inversely related to severity of coronary atherosclerosis.
    Korotaeva AA; Samoilova EV; Chepurnova DA; Zhitareva IV; Shuvalova YA; Prokazova NV
    Biomarkers; 2018 Sep; 23(6):527-532. PubMed ID: 29580104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.
    Gunes A; Schmitt C; Bilodeau L; Huet C; Belblidia A; Baldwin C; Giard JM; Biertho L; Lafortune A; Couture CY; Cheung A; Nguyen BN; Galun E; Bémeur C; Bilodeau M; Laplante M; Tang A; Faraj M; Estall JL
    Diabetes; 2023 Dec; 72(12):1820-1834. PubMed ID: 37757741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.
    Chalaris A; Schmidt-Arras D; Yamamoto K; Rose-John S
    Dig Dis; 2012; 30(5):492-9. PubMed ID: 23108305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.
    Esnault S; Khosravi M; Kelly EA; Liu LY; Bochkov YA; Tattersall MC; Jarjour NN
    Clin Exp Allergy; 2021 Apr; 51(4):564-573. PubMed ID: 33471392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
    Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10.
    Sommer J; Garbers C; Wolf J; Trad A; Moll JM; Sack M; Fischer R; Grötzinger J; Waetzig GH; Floss DM; Scheller J
    J Biol Chem; 2014 Aug; 289(32):22140-50. PubMed ID: 24973212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.
    Wonnerth A; Katsaros KM; Krychtiuk KA; Speidl WS; Kaun C; Thaler K; Huber K; Wojta J; Maurer G; Seljeflot I; Arnesen H; Weiss TW
    Metabolism; 2014 May; 63(5):647-53. PubMed ID: 24629561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.
    Sherwin JR; Smith SK; Wilson A; Sharkey AM
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
    Anderson DR; Poterucha JT; Mikuls TR; Duryee MJ; Garvin RP; Klassen LW; Shurmur SW; Thiele GM
    Cytokine; 2013 Jun; 62(3):395-400. PubMed ID: 23582716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men.
    Gray SR; Robinson M; Nimmo MA
    Cell Stress Chaperones; 2008; 13(2):247-51. PubMed ID: 18320358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 Transsignaling in Patients with Chronic Spontaneous Urticaria.
    Kasperska-Zajac A; Grzanka A; Damasiewicz-Bodzek A
    PLoS One; 2015; 10(12):e0145751. PubMed ID: 26699882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.